Manhattan Scientifics Inc (MHTX)

[ssc]

My post said "it took 2 years into the study to produce this interim result which includes 6 people".

Do you know how many patients are in the 2nd cohort?

Did you read about the need for further studies on a broader scale?

Do you understand latest financials show less than 2 quarters of cash remaining and this includes the $2.5 million tax credit?

While there may be hope for the technology someday, there is no doubt that cash is running out and probably massive dilution on the way. None of these links to articles, interviews, and promotions say otherwise and the share price confirms it.

By the way, why no mention of manny and marv metals deal as mhtx struggles to hold above a penny and they have once again burned all the easy upfront cash? Silence speaks volumes.

[rustydog62]

For those saying "only 6 patients"... Did you not read the announcement? The first cohort was 6 patients and the second cohort has already received consistent results with the first.

[ssc]

That is good news. But here is an interesting piece of the article and one of the reasons why the stock is heading toward a penny:

The Company notes that enrollment for the second cohort is ongoing with results consistent with those reported at the meeting and that further studies will be needed to broaden the study population to fully characterize the diagnostic performance of the imaging agent.

Considering it took 2 years into the study to produce this interim result which includes 6 people, how long would you think it will take to get to the end with 15 total people plus the further studies the company said will be needed? And how much more cash (and dilution)?

Looks like ibx investors should be hoping for a magic potion that stops the aging process if they ever hope to profit from their investment here.

[rustydog62]

https://imagionbiosystems.com/news/imagion-presents-magsense-interim-study-results-at-breast-cancer-meeting/

[rustydog62]

And from the collaboration agreement between PAB and IBX signed 6 months ago...

Dr. James Campbell, Patrys’ CEO and Managing Director. “The potential for our deoxymab antibodies to home in on a range of different cancer types due to their affinity for DNA is one of the properties that makes them so unique and opens up a range of different clinical applications for their use. We are very excited to be further leveraging the cancer-targeting ability of deoxymabs by partnering with Imagion and its innovative MagSense® imaging technology to potentially develop new ways to visualise and diagnose cancer. This is the first of multiple potential applications of our deoxymab platform, and while our focus is on advancing our novel cancer therapeutics to the clinic we are actively engaged in business development efforts for the broader platform to leverage theunique attributes of deoxymabs.”

[rustydog62]

From a recent email reply of James Campbell, (CEO to Patrys Limited)...

"As well as the DX1 advances, investors should keep an eye on DX3, and the fact that we are already working with other companies to explore delivery of different payloads. This could generate some non-dilutive cash for us as we push forward into the clinic"

[ssc]

That's an interesting thought. I wonder how proulx will go about raising the share price (please, not more interviews and promo videos lol). He has shown no ability to do so in recent years and has also demonstrated complete disdain for shareholder value as he has diluted to over 1 billion shares and has done placements at very low prices. Issuing another 1/2 billion shares or even another billion would not seem to concern him at all.

Hopefully a reverse split wasn't the method to be used to "raise the sp". Companies like ibx typically see the post-reverse split price quickly return to the pre-split level and dilution run wild. Unfortunaely, it looks like that would be the only thing that could get ibx back to the 20 cent ipo level.

The real question should be how long can Lake Tahoe proulx remain as ceo without delivering a completed trial and an actual plan to increase shareholder value. Amazing how those who post here refuse to hold his feet to the fire; hopefully ibx bod will soon. This has been a multi-year disaster for investors and, more important, a travesty for all who could have benefited from this technology over the last 10 years.

[Sparroww]

yes, Proulx has managed to muck it all up with that difficult trial.

yes, dilution is coming, probably before end of 2nd quarter.

no, I don't believe 2 cents is coming, he will need to raise the sp before the dilution.

"Those who have knowledge, don't predict. Those who predict, don't have knowledge"

[ssc]

Looking thru latest quarterly report from ibx (now I see why no one else mentioned it), looks like they have less than 2 quarters worth of cash left and still haven't fully enrolled the 2 year old trial. Icing on the piece of crap cake - expenses are expected to increase going forward. Anyone denying that Lake Tahoe proulx has totally screwed up the trial and is running shareholder value into the ground deserves a big piece of that cake. Big time dilution is on the way and it's going to happen with a share price close to a penny. But hey, he sure does a lot of interviews and there certainly are a lot of links being posted. That'll get you 2 cents/share, at least for a while.

[Sparroww]

helpful,, thanks.

[northside1]

This article, published in May, shows Marie Zhang of Imagion Biosystems, San Diego as an author. Hover over her name in the list of authors. https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.2c00167

[Sparroww]

Not the one I am searching for...but appreciate the effort.

Looking for the "Optimizing Magnetic Nanoparticles for MR Contrast" that they tweeted. They teased us without showing what the results showed.

[rustydog62]

I think that they were referring to this one...

https://scholar.google.com/scholar?q=Imagion+biosystems++optimizing+magnetic+nanoparticles+for+mri+contrast.&hl=en&as_sdt=0&as_vis=1&oi=scholart#d=gs_qabs&t=1670004447048&u=%23p%3DnoV6NTOz1nsJ

[ssc]

Unfortunately crying won't make all those mhtx shares purchased at much higher prices profitable. But it is understandable how the buy low and watch it go lower and lower strategy could bring on the tears.

[Sparroww]

Does anyone have a link to this work and study?

Last week @ImagionBio's Director of Product Market Development, Mee Wa Wong, was pleased to present at the @VicBioImaging Network Meeting, covering our work on Optimizing Magnetic Nanoparticles for MR Contrast. #BioMedicalImaging #Nanoparticles #IBX pic.twitter.com/LwDoSsfCrf

— Imagion Biosystems (@imagionbio) December 1, 2022

[klarino man]

Boo ~ Hoo !

[ssc]

Wow, that patent news took ibx down to .025

A few more proulx interviews and couple more great dd links and this should be sub-penny by the time new dilution hits.

Meanwhile, any updates on when that oh so important, almost 2 year old trial will be completed? How about when it will get 15 people enrolled? What a joke.

[rustydog62]

Imagion Biosystems seeks an international patent here...

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2022060924

[ssc]

ibx .0255, the potential here is to become a sub-penny stock thanks to Lake Tahoe Proulx and his still not fully enrolled almost 2 year old trial.

[ssc]

ibx - great stock for those who love to watch their investment shrink and shrink and shrink. 20 cents and getting close to sub-penny. Shrewd.

[klarino man]

I remain positive .

[klarino man]

Could be, but no way it would make any sense to you.

[ssc]

Many new clinical trials? Sounds like they're going to need a lot of cash. Could that be why the share price keeps going lower and lower?

And what about their first trial? Now almost 2 years old and still can't get 15 people to enroll. Pitiful.

[rustydog62]

IBX has just posted, (an hour ago), that they are looking for a Program Director to guide them through the many new cancer clinical trials they are about to start...

https://www.linkedin.com/mwlite/jobs/view/3307998188?referenceId=nrN10YKZQEiLnNJlPMRzDQ%3D%3D&eBP=JOB_SEARCH_ORGANIC

[rustydog62]

Nice article on IBX's potential...

https://themarketherald.com.au/imagion-biosystems-asxibx-big-things-come-in-nano-packages-2022-11-08/

[ssc]

Way to go Bob, ibx now .0265 and heading for sub-penny. How can anyone defend what this guy has done to shareholders? Even worse, the promises of this cancer fighting technology have been floated for over 10 years and still not even close to reality. Shame on these guys - manny, marv and proulx, lock them up.

[ssc]

ibx .028 - proulx must have another "nice" video on the way. This guy is as bad as marvin - just burn, burn, burn the cash and still can't get the 1st trial fully enrolled.

[ssc]

Going by history, the only one accumulating is you. You've been buying low and holding on as the stock goes lower and lower for years. No one else want this piece of crap or its spinoff ibx which is probably heading for under a penny. Good time for anyone who likes low prices that just keep going lower to buy I guess.

[klarino man]

Terrible share price but someone is accumulating ~

[ssc]

Bingo - under 3 cents. Did proulx put out yet another interview or promo video?

Sub-penny by end of the year?

[ssc]

Another proulx bullshit video and ibx hits 3 cents, down from ipo price of 20 cents. If only he could interest 15 people in the now almost 2 year old ibx trial. Something seriously wrong with this picture.

[rustydog62]

Another nice video with Bob...

https://mobile.twitter.com/xrp_digigold/status/1584271595899871232/mediaviewer

[ssc]

Trial getting close to 2 years old and proulx still can't get 15 people enrolled. Shameful. If only he enrolled 1 person for every 10 promo interviews and articles he did the trial would have been completed long ago.

[rustydog62]

"This is an important result that opens up a range of potential applications for Patrys and its development partners."


https://patrys.com/pat-dx3-crosses-blood-brain-barrier-in-healthy-animals/

[rustydog62]

For #BreastCancerAwarenessMonth, our team wanted to share stories about what motivates them to work with us, as we continually strive to provide earlier cancer detection methods to help save lives.#ThinkPink #WhyWeCare #IamAnImagioneer pic.twitter.com/S3Ta8HUGPH

— Imagion Biosystems (@imagionbio) October 12, 2022

[Sparroww]

Wonder if Proulx is second guessing his crazy idea of having human trials in Australia?

Anyone else think that a U.S. trial would have been completed by now?

No matter how many interviews or events he shows up, the lack of completion of the study is a dark cloud that hovers over his head and not providing some real evidence of what the 5-7 patients outcomes were in terms of the study is just plain stupid or perhaps he has no good news from these patients other than positive toxicology / nanoparticle results?

Until the study is completed, the stock will hover in the 3 cent AUD range, nothing brilliant about that and definitely nothing worth constantly posting about.

I will be back once we have some real news on the study. Otherwise cheers folks.

[ssc]

Good point. Proulx's interviews and promo videos combined with his horrible performance over the last 2 years have driven ibx below 3 cents USD.

[northside1]

IBX already below 3 cents USD. It is at .033 AUD which is .021 USD, One USD = 1.59 AUD,

[ssc]

Another link, more proulx interviews and promotions as first trial now almost 2 years old and still not fully enrolled. Looks like proulx is getting ready for some serious fund raising (and dilution) as, unfortunately, ibx struggles to stay above 3 cents.

Anyone catch the part where proulx says a 2nd trial will be needed - a bigger (and much more expensive) trial. How many years from now might that be completed? 2 years? 5 years? Pity those who bough into the ipo at 20 cents. This stock will be diluted into worthlessness by the time a 2nd trial gets done. How can anyone actually defend the horrible performance of lake tahoe proulx?

[rustydog62]

https://imagionbiosystems.hubspotpagebuilder.com/imagion-bio-in-the-news-oct22?ecid=ACsprvstdRn-RTlprWc0NKFono_gL_yHTGgaa1owepoh86ppYKgszjs-064QmGuaep1Q0XTnnBiE&utm_campaign=IB%20in%20the%20News&utm_medium=email&_hsmi=229134494&_hsenc=p2ANqtz--nReQ_vaana2JG0MqmSETk04EXLR1lAafAzrk_aXhTEci85VkogVLSm-iaOobyZ1SQjbD4bdjuCaQ7MRP88xqg8F6Fbg&utm_content=229134494&utm_source=hs_email

[rustydog62]

Another informative link on where IBX is headed...

[rustydog62]

https://themarketherald.com.au/imagion-biosystems-asxibx-to-present-prostate-cancer-research-in-miami-2022-09-28/

[rustydog62]

Good news for one of IBX's collaborators...

https://globalcancertechnology.com/news/

[rustydog62]

https://omny.fm/shows/fear-and-greed/interview-why-this-biotech-chose-the-asx-over-the

[ssc]

What a joke. More trials will be needed? They can't even get 15 people to participate in their 1st trial that is almost 2 years old. Burn, burn, burn the cash, no wonder share price is so low.

[rustydog62]

https://imagionbiosystems.com/news/imagion-to-present-prostate-cancer-research-data-at-wmic-2022/

[ssc]

ibx $.031, on the way to a penny so proulx can issue another billion shares or do a reverse split to finance his Lake Tahoe lifestyle. Meanwhile, can't even enroll 15 people in trial that is almost 2 years old. Who in their right mind would defend this guy?

[ssc]

ibx $.033 and proulx still can't find 15 people for the almost 2 year old trial. But life is good at Lake Tahoe.

[rustydog62]

Oops, wrong IBX company on previous link, but they do have 2 new jobs for clinical operator and manager even after just filling in 3 other jobs last month.

[rustydog62]

IBX now has federal funds in helping them to get started...

https://everglade.com/industrial-base-expansion-federal-funding/